For filings with the FSA include the annex |
|
||||||||||||||||
For filings with issuer exclude the annex |
|
||||||||||||||||
|
|||||||||||||||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
|||||||||||||||||
|
|
||||||||||||||||
1. Identity of the issuer or the underlying issuer |
Regenersis plc |
||||||||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): |
|||||||||||||||||
An acquisition or disposal of voting rights |
x |
||||||||||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
||||||||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
||||||||||||||||
An event changing the breakdown of voting rights |
|
||||||||||||||||
Other (please specify): |
|
|
|||||||||||||||
3. Full name of person(s) subject to the |
Aviva plc & its subsidiaries |
||||||||||||||||
4. Full name of shareholder(s) |
Registered Holder:
|
||||||||||||||||
5. Date of the transaction and date on |
24 February 2012 |
||||||||||||||||
6. Date on which issuer notified: |
27 February 2012 |
||||||||||||||||
7. Threshold(s) that is/are crossed or |
Total Holding less than 7% Direct Interest below 3% |
||||||||||||||||
8. Notified details: |
|||||||||||||||
A: Voting rights attached to shares viii, ix |
|||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
|||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
|||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
|||||||||||
Ordinary Shares |
3,418,066 |
3,418,066 |
3,004,587 |
1,340,482 |
1,664,105 |
2.99% |
3.71% |
||||||||
|
|||||||||||||||
|
|||||||||||||||
B: Qualifying Financial Instruments |
|||||||||||||||
Resulting situation after the triggering transaction |
|||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
|||||||||||
|
|
|
|
|
|||||||||||
|
|||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
|||||||||||||||
Resulting situation after the triggering transaction |
|||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
||||||||||
|
|
|
|
|
Nominal |
Delta |
|||||||||
|
|
||||||||||||||
Total (A+B+C) |
|
Number of voting rights |
Percentage of voting rights |
3,004,587 |
6.70% |
9. Chain of controlled undertakings through which the voting rights and/or the |
||
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-
Aviva Investors Global Services Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
|
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
See Section 4 |
|
11. Number of voting rights proxy holder will cease |
|
|
12. Date on which proxy holder will cease to hold |
|
|
|
||
|
|
|
14. Contact name: |
Neil Whittaker, Aviva plc |
|
15. Contact telephone number: |
01603 684420 |
|